ALIGOS THERAPEUTICS INC COM NEW - Stock (ALGS)

CUSIP: 01626L105

Q4 2021 13F Holders as of 31 Dec 2021

Share change
+1,683,806
SEC-reported price per share
$11.87
Number of holders
68
Value change
+$18,473,548
Number of buys
33
Number of sells
25

Security key

01626L105

Report period

Q4 2021

Institutions

68

Top holders

10

Ownership snapshot

Top reported holders of ALGS - ALIGOS THERAPEUTICS INC COM NEW - Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $59,393,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $59.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Disclosed position value Top 5
WELLINGTON MANAGEMENT GROUP LLP $59.39M
Vivo Capital, LLC $55.01M
Novo Holdings A/S $40.55M
Janus Henderson Group Ltd. $37.66M
HHLR ADVISORS, LTD. $36.68M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$59,393,000
3,829,383 shares
— 30 Sep 2021
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$55,014,000
3,547,030 shares
— 30 Sep 2021
Novo Holdings A/S
13F
Company
13F
—
denominator unverified
$40,552,000
2,614,563 shares
— 30 Sep 2021
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$37,657,000
2,440,476 shares
— 30 Sep 2021
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$36,682,000
2,365,064 shares
— 30 Sep 2021
Versant Venture Management, LLC
13F
Company
13F
—
denominator unverified
$35,989,000
2,320,381 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
68
Shares
32,893,048
Rows available
68
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q4 2021 holders
68
Holder diff
67
Investor Q1 2026 Shares Q4 2021 Shares Share Diff Share Chg % Q1 2026 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .